PT  - JOURNAL ARTICLE
AU  - Alzueta, Natalia
AU  - Echeverría, Amaya
AU  - Sanz, Lorea
AU  - Fontela, Carmen
AU  - Acín, Teresa
AU  - Montenegro, Lidia
AU  - Garjón, Javier
TI  - Telmisartan-induced sprue-like enteropathy: a case report
AID  - 10.1136/ejhpharm-2018-001669
DP  - 2020 Jan 01
TA  - European Journal of Hospital Pharmacy
PG  - 49--51
VI  - 27
IP  - 1
4099  - http://ejhp.bmj.com/content/27/1/49.short
4100  - http://ejhp.bmj.com/content/27/1/49.full
SO  - Eur J Hosp Pharm2020 Jan 01; 27
AB  - A possible case of sprue-like enteropathy (SLE) induced by the use of telmisartan is reported. Telmisartan is an angiotensin-receptor II blocker (type 1) used for the treatment of hypertension. Several cases of SLE associated with olmesartan and other drugs of the same group have been reported. In all cases, SLE resolved following therapy withdrawal. We describe the case of an 80-year-old woman who presented with diarrhoea and abdominal pain. In the past 5 years she had been treated with telmisartan 40 mg once a day for hypertension, so we hypothesised that symptoms might be caused by telmisartan. After treatment discontinuation, diarrhoea disappeared. Three causality algorithms were applied and revealed a possible or likely causal relationship. At present, the patient remains asymptomatic. There is a causal relationship between the use of telmisartan and SLE. This association should be taken into account by physicians when prescribing and reviewing drug therapies.